You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 132 No. 4, April 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  CORRESPONDENCE: COMMENTS AND OPINIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Mycosis Fungoides Palmaris et Plantaris-Reply

Kenneth Resnik, MD
Department of Dermatology Hahnemann University Mailstop 478 Broad and Vine Philadelphia, PA 19102

Gary Kantor, MD; Stuart Lessin, MD; Eric Vonderheid, MD
Philadelphia

Marshall Kadin, MD
Boston, Mass

Arch Dermatol. 1996;132(4):468-469.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The aim of the article titled, "Mycosis Fungoides Palmaris et Plantaris," is to alert clinicians that mycosis fungoides (MF) may be limited to palms and soles, and MF should be a diagnostic consideration in recalcitrant palmoplantar dermatitides. Our reasons to include cases of Woringer-Kolopp disease (WKD) as a variant of MF are stated in the "Comment" section of the article and provide justification for including cases of WKD that involve the palms or soles as part of our series of mycosis fungoides palmaris et plantaris.

Although Dr Smoller objects to the inclusion in our series of his and other cases of WKD in which the neoplastic T cells express the CD8+ phenotype, we question whether the immunophenotype of the neoplastic cell per se is sufficient reason to define WKD as a distinct entity. It has been shown that CD8 expression occurs in about 5% of the cases diagnosed as MF . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.